Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.05 | 0.7 |